<p>Dr. Charles Rudin of Memorial Sloan Kettering on how PARP inhibitors may benefit patients with small cell lung cancer. February 2014.</p>

Dr. Charles Rudin of Memorial Sloan Kettering on how PARP inhibitors may benefit patients with small cell lung cancer. February 2014.

What Are PARP Inhibitors, and Might They Improve Outcomes in Small Cell Lung Cancer?

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

Share What Are PARP Inhibitors, and Might They Improve Outcomes in Small Cell Lung Cancer?

Sign up to save your podcasts

What Are PARP Inhibitors, and Might They Improve Outcomes in Small Cell Lung Cancer?

What Are PARP Inhibitors, and Might They Improve Outcomes in Small Cell Lung Cancer?

More shows like GRACEcast Radiation Oncology Audio

GRACEcast Head and Neck Cancer Audio

GRACEcast Lung Cancer Video

GRACEcast Radiation Oncology Video

GRACEcast Pancreatic Cancer Audio

GRACEcast Pancreatic Cancer Video

GRACEcast Cancer 101 Audio

GRACEcast Bladder Cancer Video

GRACEcast Head and Neck Cancer Video NEW

GRACEcast Cancer 101 Video